Wolfgang Oster

5.4k citations
102 papers · 3.0k · 1 hit paper · h-index 29

Impact in

    • Head and Neck Cancer Studies
  • Hematology top 1%
    • Hematopoietic Stem Cell Transplantation
    • Acute Myeloid Leukemia Research

Papers in

    • Cancer Treatment and Pharmacology 9
    • Cancer therapeutics and mechanisms 13
    • Receptor Mechanisms and Signaling 7

Wolfgang Oster

97 papers receiving 2.9k citations

Wolfgang Oster's Hit Papers

Phase III Randomized Trial of Amifostine as a Radioprotector in Head and Neck Cancer 2000 · 622 citations
6220+8+17Years since publication200400600

Peers

Wolfgang Oster
Comparison fields: 5 of 103
  • Otorhinolaryngology 242
  • Hematology 629
  • Genetics 385
  • Immunology 763
  • Oncology 652
Replace Michele Del Vecchio with:
Michele Del Vecchio Italy
David T. Yang United States
Kalle Alanen Finland
Christopher Ocampo United States
Frédéric FIORE France
Meier Hsu United States
Leroy M. Parker United States
Ivan Ding United States
Hidayatullah G. Munshi United States
Kyubo Kim South Korea
Wolfgang Oster relative to Michele Del Vecchio Italy Michele Del Vecchio's profile →
Citations per field
00.5×8.0×
Michele Del Vecchio · 1×
Citations per year

Countries citing papers authored by Wolfgang Oster

Since Specialization
Citations

This map shows the geographic impact of Wolfgang Oster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wolfgang Oster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wolfgang Oster more than expected).

Fields of papers citing papers by Wolfgang Oster

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wolfgang Oster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wolfgang Oster. The network helps show where Wolfgang Oster may publish in the future.

Co-authors

The 25 scholars most cited alongside Wolfgang Oster, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Wolfgang Oster Line = papers co-authored together Wolfgang Oster links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 102 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Phase III Randomized Trial of Amifostine as a Radioprotector in Head and Neck Cancer
Hit paper breakdown →
2000622
2 1987158
3 1989151
4 1988134
5 1990122
6 2017113
7 198991
8 198986
9 199983
10 198978
11 198969
12 198963
13 198961
14 201961
15 200059
16 199758
17 200058
18 201756
19 201955
20 201953

About Wolfgang Oster

Wolfgang Oster is a scholar working on Oncology, Molecular Biology, Hematology, Immunology and Genetics, having authored 102 papers that have together received 3.0k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (14 papers), Acute Myeloid Leukemia Research (14 papers), Cancer therapeutics and mechanisms (13 papers), Glioma Diagnosis and Treatment (13 papers), Immune Response and Inflammation (12 papers), Cancer Treatment and Pharmacology (9 papers), Cancer, Hypoxia, and Metabolism (8 papers) and Receptor Mechanisms and Signaling (7 papers). The work is most often cited by research in Otorhinolaryngology (242 citations), Hematology (629 citations), Genetics (385 citations), Immunology (763 citations) and Oncology (652 citations). Wolfgang Oster has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include F. Herrmann, A. Lindemann, R Mertelsmann, Rolf Sauer, Todd H. Wasserman, David M. Brizel, Roland Mertelsmann, Lesley Russell, Alain Monnier and Michael Henke. Their work appears in journals such as Journal of Clinical Oncology, Blood, Neuro-Oncology, European Journal of Cancer and Annals of Hematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact